Evidence map›Paper›PMID 32640046›Full record

ArticleElectrophoresis2021

Four-step approach to efficiently develop capillary gel electrophoresis methods for viral vaccine protein analysis.

Lars Geurink, Ewoud van Tricht, Justin Dudink, Bojana Pajic, Cari E Sänger-van de Griend

Abstract read
In one paragraph

Article in Electrophoresis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lars GeurinkJanssen Vaccines and Prevention B.V., Leiden, The Netherlands.ORCID 0000-0002-6932-6602
Ewoud van TrichtJanssen Vaccines and Prevention B.V., Leiden, The Netherlands.ORCID 0000-0002-8001-4538
Justin DudinkJanssen Vaccines and Prevention B.V., Leiden, The Netherlands.
Bojana PajicJanssen Vaccines and Prevention B.V., Leiden, The Netherlands.
Cari E Sänger-van de GriendFaculty of Pharmacy, Department of Medicinal Chemistry, Biomedical Centre, Uppsala University, Uppsala, Sweden.ORCID 0000-0001-8409-4443

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vaccines against infectious diseases are urgently needed. Therefore, modern analytical method development should be as efficient as possible to speed up vaccine development. The objectives of the study were to identify critical method parameters (CMPs) and to establish a set of steps to efficiently develop and validate a CE-SDS method for vaccine protein analysis based on a commercially available gel buffer. The CMPs were obtained from reviewing the literature and testing the effects of gel buffer dilution. A four-step approach, including two multivariate DoE (design of experiments) steps, was proposed, based on CMPs and was verified by CE-SDS method development for: (i) the determination of influenza group 1 mini-hemagglutinin glycoprotein; and (ii) the determination of polio virus particle proteins from an inactivated polio vaccine (IPV). The CMPs for sample preparation were incubation temperature(s) and time(s), pH, and reagent(s) concentration(s), and the detection wavelength. The effects of gel buffer dilution revealed the CMPs for CE-SDS separation to be the effective length, the gel buffer concentration, and the capillary temperature. The four-step approach based on the CMPs was efficient for the development of the two CE methods. A four-step approach to efficiently develop capillary gel electrophoresis methods for viral vaccine protein analysis was successfully established.

Indexed as

Viral ProteinsViral VaccinesElectrophoresis, CapillaryResearch DesignSodium Dodecyl SulfateSodium Dodecyl SulfateViral ProteinsViral VaccinesAnalytical quality by designCE-SDSInactivated polio virusMini-hemagglutininViral vaccine protein

Identifiers

PMID32640046
PMCPMC7361255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.